Precigen, Inc.
PGEN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001356090
In the last 90 days, Precigen, Inc. insiders filed 1 open-market purchase and 9 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $799.4M in total; no superinvestor holds it.
Holders of 5% or more of PGEN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Precigen, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Kirk Randal J | 13D/A | 35.90%134.0M shares | −2.20 ppfrom 38.10% | Oct 7, 20228 filings | Mar 31, 2026 | SEC |
| Patient Capital Management, LLC | 13G/A | 10.20%36.0M shares | −3.40 ppfrom 13.60% | Feb 14, 20245 filings | Feb 13, 2026 | SEC |
| Miller William H III | 13G | 9.20%34.1M shares | New | Sep 23, 20251 filing | Sep 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on Precigen, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 202611:23 AM ET | Merck KGaAand 3 others | 13G/A | 4.90%17.5M shares | –Below 5% | Jun 9, 2026 | SEC |
| May 15, 20264:32 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 1.90%6.74M shares | −3.30 ppfrom 5.20%Below 5% | Mar 31, 2026 | SEC |
| Mar 31, 20264:01 PM ET | Kirk Randal Jand 2 others | 13D/A | 35.90%134.0M shares | −2.20 ppfrom 38.10% | Mar 30, 2026 | SEC |
| Feb 13, 202610:56 AM ET | Patient Capital Management, LLCand 1 other | 13G/A | 10.20%36.0M shares | −3.40 ppfrom 13.60% | Dec 31, 2025 | SEC |
| Jan 23, 20264:05 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 5.20%18.4M shares | New | Jan 22, 2026 | SEC |
| Nov 21, 20258:23 PM ET | Kirk Randal Jand 2 others | 13D/A | 38.10%141.5M shares | −1.30 ppfrom 39.40% | Nov 19, 2025 | SEC |
| Oct 30, 202512:49 PM ET | Patient Capital Management, LLCand 1 other | 13G/A | 13.60%45.2M shares | +7.07 ppfrom 6.53% | Dec 31, 2024 | SEC |
| Sep 23, 20254:06 PM ET | Miller William H III | 13G | 9.20%34.1M shares | New | Jun 26, 2025 | SEC |
| Sep 19, 20258:55 PM ET | Kirk Randal Jand 3 others | 13D/A | 39.40%146.3M shares | −0.40 ppfrom 39.80% | Sep 17, 2025 | SEC |
| Feb 12, 202510:51 AM ET | Patient Capital Management, LLC | 13G/A | 6.53%17.7M shares | – | Dec 31, 2024 | SEC |
| Dec 30, 20247:29 PM ET | Kirk Randal Jand 3 others | 13D/A | 39.80%116.8M shares | – | Dec 30, 2024 | SEC |
| Aug 13, 2024 | Kirk Randal J | 13D/AOld format | – | – | – | SEC |
| May 3, 2024 | Kirk Randal J | 13D/AOld format | – | – | – | SEC |
| Feb 27, 2024 | Patient Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ares Trading S.A. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Patient Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Jan 31, 2023 | Kirk Randal J | 13D/AOld format | – | – | – | SEC |
| Jan 27, 2023 | Ares Trading S.A. | 13G/AOld format | – | – | – | SEC |
| Oct 7, 2022 | Kirk Randal J | 13D/AOld format | – | – | – | SEC |
| Jan 24, 2022 | Ares Trading S.A. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Miller Value Partners, LLC | 13G/AOld format | – | – | – | SEC |
| Jan 8, 2021 | Ares Trading S.A. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Precigen, Inc. shares.
No Form 144 notices for Precigen, Inc. are on file.